Search research articles
Contact Us
Filters
Showing results (231-240 of 236) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 236 results.
Molecular Pharmaceutics
|
September 4, 2020
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel
Niloufar Salehi, Jozef Al-Gousous, Deanna M Mudie, et al.
Molecular Pharmaceutics
|
December 20, 2023
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer
Patrick D Sinko, Niloufar Salehi, Troy Halseth, et al.
Arthritis and Rheumatism
|
September 1, 1977
Anti-tissue antibodies in rheumatic disease: standardization and nomenclature
E M Tan, C Christian, H R Holman, et al.
Molecular Pharmaceutics
|
August 24, 2021
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis
Niloufar Salehi, Gislaine Kuminek, Jozef Al-Gousous, et al.
Nature Catalysis
|
November 2, 2020
Elucidating structure-performance relationships in whole-cell cooperative enzyme catalysis
Mason R Smith, Hui Gao, Ponnandy Prabhu, et al.
International Journal of Pharmaceutics
|
June 27, 2018
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project
Bart Hens, Patrick D Sinko, Nicholas Job, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 236) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 236 results.
Molecular Pharmaceutics
|
September 4, 2020
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel
Niloufar Salehi, Jozef Al-Gousous, Deanna M Mudie, et al.
Molecular Pharmaceutics
|
December 20, 2023
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer
Patrick D Sinko, Niloufar Salehi, Troy Halseth, et al.
Arthritis and Rheumatism
|
September 1, 1977
Anti-tissue antibodies in rheumatic disease: standardization and nomenclature
E M Tan, C Christian, H R Holman, et al.
Molecular Pharmaceutics
|
August 24, 2021
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis
Niloufar Salehi, Gislaine Kuminek, Jozef Al-Gousous, et al.
Nature Catalysis
|
November 2, 2020
Elucidating structure-performance relationships in whole-cell cooperative enzyme catalysis
Mason R Smith, Hui Gao, Ponnandy Prabhu, et al.
International Journal of Pharmaceutics
|
June 27, 2018
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project
Bart Hens, Patrick D Sinko, Nicholas Job, et al.
Page
of 24